您的位置: 首页 > 农业专利 > 详情页

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
专利权人:
Yeda Research and Development Co. Ltd.
发明人:
Eisenbach-Schwartz, Michal,Baruch, Kuti,Rosenzweig, Neta
申请号:
AU2018220155
公开号:
AU2018220155B2
申请日:
2018.08.24
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
#$%^&*AU2018220155B220191205.pdf#####ABSTRACT: A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing- remitting multiple sclerosis (RRMS), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two courses of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充